The British Nuclear Medicine Society (BNMS) was established in 1966 and is an independent forum devoted to various aspects of nuclear medicine in the UK. The mission statement of BNMS is "the advancement of science and public education in Nuclear Medicine that would benefit patients." [1] As of 2020 the BNMS has over 600 members.[ citation needed ] The BNMS is a registered company and charity.
Founders Edward Williams, David Keeling, Steve Garnett, and Ralph McCready [2] formed the society during a meeting held July 1966 at the Prince Alfred pub in Queensway, London. [3] [4] The BNMS began its life as a Nuclear Medicine Society, which was meant to enhance the future prospects of physicians in nuclear medicine. The first president of the society during 1968-69 was Clive J Hayter from Leeds. [5] The organization held annual conferences since 1972. [6] The BNMS hosted the second joint meeting under the presidency of Keith Britton in London in 1985, attended by 3000 participants.
In 2016, BNMS celebrated its fiftieth anniversary and published a 170-page "History of Radionuclide Studies in the UK". [3]
It is headquartered on the Jubilee Campus of the University of Nottingham.
BNMS publishes a monthly journal, Nuclear Medicine Communications . [7] Key events of the society include the biannual conference as well as participation in smaller, subject-specific, meetings and workshops. [8]
BNMS publishes a range of guidance documents for nuclear medicine departments including on; patient information leaflets, [9] [10] the tendering of equipment, diagnostic imaging and non-imaging procedures, therapeutic procedures, and training requirements. [11] [12] [13] Its clinical guidance is indexed in the National Institute for Health and Care Excellence evidence search. [14]
The society and its UK Radiopharmacy Group provide resources for radiopharmacies in the UK, as well as work relating to supply issues for medical radionuclides, which largely come from outside the UK. [15] [16] This included several publications related to the impact of a no-deal Brexit. [17] [18]
The Society sometimes gives awards to individuals and teams [19] in the area of nuclear medicine in UK for using innovation and creativity to improve their service to public.
Nuclear medicine or nucleology is a medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease. Nuclear imaging, in a sense, is "radiology done inside out" because it records radiation emitted from within the body rather than radiation that is transmitted through the body from external sources like X-ray generators. In addition, nuclear medicine scans differ from radiology, as the emphasis is not on imaging anatomy, but on the function. For such reason, it is called a physiological imaging modality. Single photon emission computed tomography (SPECT) and positron emission tomography (PET) scans are the two most common imaging modalities in nuclear medicine.
Radiopharmacology is radiochemistry applied to medicine and thus the pharmacology of radiopharmaceuticals. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases. Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide. In the book Technetium a total of 31 different radiopharmaceuticals based on Tc-99m are listed for imaging and functional studies of the brain, myocardium, thyroid, lungs, liver, gallbladder, kidneys, skeleton, blood and tumors.
A rectilinear scanner is an imaging device, used to capture emission from radiopharmaceuticals in nuclear medicine. The image is created by physically moving a radiation detector over the surface of a radioactive patient. It has become obsolete in medical imaging, largely replaced by the gamma camera since the late 1960s.
Radiographers, also known as radiologic technologists, diagnostic radiographers and medical radiation technologists are healthcare professionals who specialise in the imaging of human anatomy for the diagnosis and treatment of pathology. Radiographers are infrequently, and almost always erroneously, known as x-ray technicians. In countries that use the title radiologic technologist they are often informally referred to as techs in the clinical environment; this phrase has emerged in popular culture such as television programmes. The term radiographer can also refer to a therapeutic radiographer, also known as a radiation therapist.
The Society of Radiographers (SoR) is a professional body and trade union that represents more than 90 percent of the diagnostic and therapeutic radiographers in the United Kingdom. The College of Radiographers (CoR) is a charitable subsidiary of the Society, they are collectively known as the Society and College of Radiographers (SCoR).
The International Commission on Radiological Protection (ICRP) is an independent, international, non-governmental organization, with the mission to protect people, animals, and the environment from the harmful effects of ionising radiation. Its recommendations form the basis of radiological protection policy, regulations, guidelines and practice worldwide.
Nuclear pharmacy, also known as radiopharmacy, involves preparation of radioactive materials for patient administration that will be used to diagnose and treat specific diseases in nuclear medicine. It generally involves the practice of combining a radionuclide tracer with a pharmaceutical component that determines the biological localization in the patient. Radiopharmaceuticals are generally not designed to have a therapeutic effect themselves, but there is a risk to staff from radiation exposure and to patients from possible contamination in production. Due to these intersecting risks, nuclear pharmacy is a heavily regulated field. The majority of diagnostic nuclear medicine investigations are performed using technetium-99m.
The Institute of Physics and Engineering in Medicine (IPEM) is the United Kingdom's professional body and learned society for physicists, engineers and technologists within the field of medicine, founded in 1995, changing its name from the Institution of Physics and Engineering in Medicine and Biology (IPEMB) in 1997. The Institute is governed by an elected Board of Trustees reporting to which are the Science, Research and Innovation Council and the Professional and Standards Council. The councils have operational responsibility for scientific and professional aspects of the Institute's work, respectively. Beneath the councils is a substructure of committees, groups and panels of members, which undertake the work of the Institute.
The American Society of Radiologic Technologists (ASRT) is a professional membership association that serves medical imaging technologists, radiation therapists, and radiologic science students. The organization, located in Albuquerque, New Mexico provides its members with ongoing education and professional development opportunities.
Abass Alavi is an Iranian-American physician-scientist specializing in the field of molecular imaging, most notably in the imaging modality of positron emission tomography (PET). In August 1976, he was part of the team that performed the first human PET studies of the brain and whole body using the radiotracer [18F]Fluorodeoxyglucose (FDG). Alavi holds the position of Professor of Radiology and Neurology, as well as Director of Research Education in the Department of Radiology at the University of Pennsylvania. Over a career spanning five decades, he has amassed over 2,300 publications and 60,000 citations, earning an h-index of 125 and placing his publication record in the top percentile of scientists.
Nuclear medicine physicians, also called nuclear radiologists or simply nucleologists, are medical specialists that use tracers, usually radiopharmaceuticals, for diagnosis and therapy. Nuclear medicine procedures are the major clinical applications of molecular imaging and molecular therapy. In the United States, nuclear medicine physicians are certified by the American Board of Nuclear Medicine and the American Osteopathic Board of Nuclear Medicine.
The Society for Radiological Protection is the leading UK professional body promoting learning and skills in the field of Radiological Protection. The Society was formed in 1963, and received its Royal Charter in 2007. It has the overall objectives of improving public knowledge and maintaining professional standards in that field. It is the largest society of its kind in Europe, and second largest in the world.
The European Federation of Organisations for Medical Physics (EFOMP) was founded in May 1980 in London to serve as an umbrella organisation representing the national Medical Physics societies in Europe. The office moved to Utrecht in January 2021. It is a non-profit organisation and aims to foster and coordinate the activities of its national member organisations, encourage exchange and dissemination of professional and scientific information, develop guidelines for education, training and accreditation programmes and to make recommendations on the responsibilities, organisational relationships and roles of medical physicists.
Nuclear Medicine Communications is an official journal of the British Nuclear Medicine Society based in Nottingham, United Kingdom. The journal publishes studies based on radionuclide imaging for basic, preclinical, and clinical research. Areas of interest include radiochemistry, radiopharmacy, radiobiology, radiopharmacology, medical physics, computing and engineering, and technical and nursing professions involved in delivering nuclear medicine services.
Jamshed Bomanji is a full professor, clinical lead, and head of the Institute of Nuclear medicine department at the University College Hospital (UCLH) NHS foundation trust based in London, UK.
Ignac Fogelman was a professor of Nuclear Medicine at King’s College London, Honorary Consultant Physician at Guy’s and St Thomas’ NHS Trust, and Director of the Osteoporosis Screening & Research Unit at Guy’s Hospital. He was born in 1948 in Germany and died on 5 July 2016 in the United Kingdom. He is known as the father of bone imaging by some researchers and academics.
Vasudeva Kilara Iya is an Indian nuclear scientist and the First Head of the radioisotope and radiation technology programme of the Department of Atomic Energy (DAE) and a former Group Director at BARC (1974-1987).
A clinical technologist, also known as a healthcare science practitioner, is a medical professional involved in the practical delivery of medical physics and clinical engineering services. In some locations there is considerable overlap in closely related terms, for example in many countries technologist and radiographer are synonyms, while in the United Kingdom they are considered separate professions. Clinical technologists can be found in nuclear medicine, radiotherapy, radiation protection, and rehabilitation engineering departments, and they are often described by their scope of practice.
CERN-MEDical Isotopes Collected from ISOLDE (MEDICIS) is a facility located in the Isotope Separator Online DEvice (ISOLDE) facility at CERN, designed to produce high-purity isotopes for developing the practice of patient diagnosis and treatment. The facility was initiated in 2010, with its first radioisotopes (terbium-155) produced on 12 December 2017.